American Health Council Names Eric A. Widra, M.D. to

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
94
American Health Council Names Eric A. Widra, M.D. to Physician Board

NEW YORK, July 10, 2017 (GLOBE NEWSWIRE) -- Dr. Eric Widra, Physician and Medical Director at Shady Grove Fertility, has been selected to join the Physician Board at the American Health Council. He will be sharing his knowledge and expertise in Obstetrics, Gynecology, and Reproductive Endocrinology.

Amassing two decades of experience in the field of Obstetrics and Gynecology, Dr. Widra utilizes his expertise in his role as a Physician and Medical Director at Shady Grove Fertility.  Recognized on as a world leader and respected pioneer in fertility treatment, Shady Grove Fertility was founded by Dr. Michael J. Levy and Arthur W. Sagoskin over twenty-six years ago to provide cutting edge fertility care in an environment that supported patients' physical, emotional, and financial needs—and to make future business and clinical decisions based on what is in the best interest of the patients. Available in fifty states and thirty-five countries, Shady Grove Fertility is staffed with highly qualified healthcare professionals while incorporating the latest in medical technology and equipment to perform basic and advanced treatments.

In his current capacity as a Physician and Medical Director at Shady Grove Fertility since 2013, Dr. Widra’s day-to-day responsibilities include patient consults, research, the supervision of physicians, and ventures for his practice. He is board certified in Gynecology and Reproductive Endocrinology by the American Board of Obstetrics and Gynecology.

Beyond serving as supervisor of the research program at Shady Grove Fertility, Dr. Widra serves as a site director for the Combined Federal Fellowship in Reproductive Endocrinology and Infertility in Metro Washington, DC, which is the largest fellowship program of its kind.

Following graduation with his medical degree from the Rutgers University in 1990, Dr. Widra pursued an internship (1991) and residency (1994) in Obstetrics & Gynecology at Thomas Jefferson University Hospital. In 1996, he completed a fellowship in Reproductive Endocrinology at George Washington University Hospital. 

As a testament to his success, Dr. Widra has been honored to be selected to Washingtonian’s Top Doctor List for Infertility (1994 - Present) and the Washington Consumers’ Checkbook Guide to Top Doctors (2015). Due to his consistent presentation at the annual American Society of Reproductive Medicine meetings, Dr. Widra has been a recipient of the ASRM Star Award. He has authored over sixty publications in fertility journals, such as Fertility and Sterility, Human Reproduction, and the Journal of Assisted Reproduction and Genetics.

To keep abreast of the latest in the industry, Dr. Widra maintains a membership with the Society for Assisted Reproductive Technology (SART) and American Society for Reproductive Medicine (ASRM). He serves on the Board of Directors of RESOLVE: The National Infertility Organization.

Looking back, Dr. Widra attributes his success to luck, his strong work ethic and commitment to research which has led to the best possible treatments for patients. He is most proud to be part of a growing and successful practice assisting patients through infertility.

Considering the future, Dr. Widra hopes for the continued growth of his practice.

About the American Health Council:

The American Health Council is the nation’s only organization with a constituency representative of all sectors of the healthcare industry. From the coasts to the heartland, the American Health Council has drawn Affiliates from major metropolitan hubs and small communities. These Affiliates span generations and have reached different stages of their careers — from recent graduates to retirees. More information about the American Health Council and its mission can be found at: http://americanhealthcouncil.org

Additionally, the American Health Council strives to provide recognition and support for those individuals and institutions making the difference in patients’ lives day in and day out. Throughout 2017, the AHC is honoring “America’s Best Doctors and Nurses,” as well as the nation’s best medical universities and hospitals. The American Health Council’s “Best in Medicine” and “Best in Nursing” awards programs honor the individuals and institutions that have contributed significantly to medicine and nursing, as well as the training and education of physicians and nurses. The most current selections for these honors may be viewed here: http://bestinmedicine.org and http://bestinnursing.org . 

For more information, please contact: Elizabeth Moore American Health Council Hauppauge, NY United States Phone: 1-212-390-0214 Email: media@americanhealthcouncil.org

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 15

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 25

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 31

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 30

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 23

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 30

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 22

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading

Top 5 Most Recently Viewed Articles

Quaker Chemical Experiences 52-Week Low Amid Market Challenges

Updated Category News Views 129

Quaker Chemical Faces Significant Market Challenges In a challenging market climate, Quaker Chemical Corporation (NYSE: KWR) recently saw its stock plummet to a 52-week low of $138.97. This specialty chemical company, renowned for its high-performance process fluids and coatings utilized in metalworking, has undergone considerable struggles over the past year, leading to...

Continue Reading
Aura Minerals Completes Significant Bluestone Acquisition

Updated Category News Views 124

Aura Minerals Completes Acquisition of Bluestone Resources Aura Minerals Inc. (TSX: ORA) has successfully executed its acquisition of Bluestone Resources Inc. (BBSRF) through a strategic arrangement. This transaction signals a notable expansion for Aura as it aims to enhance its precious metals portfolio. Terms of the Acquisition Under the recent agreement, shareholders...

Continue Reading
Revolutionizing Employee Benefits with Cutting-Edge Automation

Updated Category News Views 176

Employee Benefits Marketing Transformation In the landscape of employee benefits, there lies a pressing need for innovation, especially regarding effective communication and marketing engagement. Businessolver, a recognized leader in HR and benefits technology, has taken significant strides with the introduction of its Benefits Communication and Automation Engine. This...

Continue Reading
Understanding the Net Asset Value of Middlefield PCC Today

Updated Category News Views 84

Middlefield Canadian Income PCC Overview Middlefield Canadian Income PCC is a distinct investment option that focuses on providing income opportunities. Established as a protected cell company in Jersey, it adheres to well-defined regulatory standards, adding a layer of security for those who invest in it. Net Asset Value Insights In a recent evaluation, the estimated...

Continue Reading
Tarsus Pharmaceuticals Participates in Healthcare Conference

Updated Category News Views 102

Tarsus Pharmaceuticals Engages in Important Healthcare Conference Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) is committed to meeting unmet medical needs through innovative scientific advancements and cutting-edge technology. The company places a strong emphasis on eye care, with the goal of transforming the treatment landscape for patients. Recently, Tarsus announced...

Continue Reading